Maravai LifeSciences Holdings, Inc. - Class A common stock (MRVI) analyst actions
MRVI analyst actions moved a median of -0.32% by the close. Rating and price-target actions on MRVI in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the MRVI overview →
15 measured MRVI analyst action events.
Where these MRVI analyst actions landedvs 15 measured MRVI analyst action reactions
| Middle 50% of MRVI analyst action reactions | -1.90% to +0.96% |
|---|---|
| Median reaction (to close) | -0.32% |
| Measured reactions | 15 |
Point-in-time · zero look-ahead
Half of the 15 MRVI analyst action events with a measured close landed between -1.90% and +0.96%; 40% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out | Press release | +4.57% | +3.71% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out | Press release | -0.42% | -0.14% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out | Press release | +0.16% | -0.32% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out | Press release | +1.92% | +0.82% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out | Press release | +0.27% | +0.67% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out | Press release | +0.00% | +2.04% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out | Press release | -0.84% | -5.34% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out | Press release | -0.87% | -1.76% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out | Press release | -1.10% | +1.10% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out | Press release | +0.52% | +3.14% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out | Press release | -0.41% | -2.04% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out | Press release | -0.56% | -0.74% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out | Press release | +0.22% | -5.88% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out | Press release | +1.15% | -0.46% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out | Press release | -0.51% | -3.73% |
Keep exploring
More MRVI: earnings → · SEC filings → · MRVI overview →